In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mid-Sized Pharma in Mega-Sized Markets

Executive Summary

As it begins to market its own version of the popular drug Ritalin, Alza Corp. is likely to encounter physicians with their own kind of attention deficit disorder. Alza hopes to distinguish Concerta from a crowd of ADHD drugs already on the market, by stressing its compliance advantage. But Alza needs extra sales help. It thus signed up McNeil Consumer HealthCare to co-promote Concerta.
Advertisement

Related Content

Shire Shifts Upstream

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel